Innovative Shampoo-Like Gel Could Help Preserve Hair During Chemotherapy

A groundbreaking shampoo-like hydrogel developed by Michigan State University aims to protect hair follicles from damage during chemotherapy, offering a new hope for cancer patients experiencing hair loss. Source: https://medicalxpress.com/news/2025-09-shampoo-gel-chemo-patients-hair.html
Researchers at Michigan State University have developed a novel shampoo-like hydrogel aimed at protecting hair follicles from damage during chemotherapy. Chemotherapy-induced hair loss can cause significant emotional, social, and professional distress among cancer patients. Currently, limited solutions, such as costly cold caps with potential side effects, are used to mitigate this issue.
The new hydrogel gel, which has the consistency of shampoo, is formulated to be applied to the scalp before starting chemotherapy. The gel contains the active ingredients lidocaine and adrenalone, which work to restrict blood flow around hair follicles. This reduction in blood flow limits the amount of chemotherapeutic drugs reaching the follicles, thereby helping to prevent hair loss.
A key feature of the gel is its temperature responsiveness: at body temperature, it adheres firmly to the scalp and hair, offering sustained protection. When exposed to cooler temperatures, it becomes more fluid and can be easily washed away. This innovative approach aims to provide a practical, non-invasive solution that can be easily used by patients.
The hydrogel's design leverages its water-absorbing capacity and ability to deliver drugs over long periods. Once applied, it remains on the scalp during chemotherapy circulation and prevents the drugs from damaging hair follicles. The research team is seeking funding to advance into clinical trials, with the ultimate goal of making this protective gel available for human use.
This development represents a significant step towards improving the quality of life for cancer patients, addressing an unmet need with a safe and potentially effective solution based on well-established materials. The findings have been detailed in a paper published in Biomaterials Advances.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Final Results Confirm Effectiveness of Two-Drug Therapy for Advanced Kidney Cancer
A comprehensive five-year clinical trial confirms the long-term effectiveness of the pembrolizumab plus axitinib combination in treating advanced kidney cancer, offering new hope for improved survival outcomes.
Innovative Algorithm Aims to Correct False Penicillin Allergy Labels in Community Pharmacy Settings
Researchers from Monash University have developed an algorithm to identify and de-label incorrect penicillin allergy labels in community pharmacy settings, improving antibiotic use and tackling antimicrobial resistance.
Delayed Extubation of Ventilator Tubes in Patients May Increase Health Risks
Research reveals that delays in removing ventilator tubes after successful breathing tests can increase health risks, emphasizing the importance of timely extubation practices.
Antibiotics and Energy Inhibitors Show Promise in Targeting Aggressive Melanoma Cells by Disrupting Mitochondrial Function
New research reveals that antibiotics and energy inhibitors can specifically target and kill aggressive melanoma cells by disrupting mitochondrial energy pathways, offering a promising new treatment strategy.



